127 200

Cited 10 times in

Growth hormone treatment and risk of malignancy

 Hyun Wook Chae  ;  Duk Hee Kim  ;  Ho Seong Kim 
 Korean Journal of Pediatrics, Vol.58(2) : 41-46, 2015 
Journal Title
 Korean Journal of Pediatrics 
Issue Date
Growth hormone ; Malignancy insulin-like growth factor-I ; Neoplasms ; Recurrence
Growth hormone (GH) treatment has been increasingly widely used for children with GH deficiencies as the survival rate of pediatric patients with malignancies has increased. Both GH and insulin-like growth factor-I have mitogenic and antiapoptotic activity, prompting concern that GH treatment may be associated with tumor development. In this review, the authors examined the relationship between GH treatment and cancer risk in terms of de novo malignancy, recurrence, and secondary neoplasm. Although the results from numerous studies were not entirely consistent, this review of various clinical and epidemiological studies demonstrated that there is no clear evidence of a causal relationship between GH treatment and tumor development. Nonetheless, a small number of studies reported that childhood cancer survivors who receive GH treatment have a small increased risk of developing de novo cancer and secondary malignant neoplasm. Therefore, regular follow-ups and careful examination for development of cancer should be required in children who receive GH treatment. Continued surveillance for an extended period is essential for monitoring long-term safety.
Files in This Item:
T201500852.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Ho Seong(김호성) ORCID logo https://orcid.org/0000-0003-1135-099X
Chae, Hyun Wook(채현욱) ORCID logo https://orcid.org/0000-0001-5016-8539
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.